Immunohistochemical (IHC) staining was used to quantify DDA1 levels as well as NFκB pathway activation, as measured by p65 nuclear translocation, in 101 relapsed and 178 nonrelapsed patients with stage II colon cancer. Here, RELA is linked to malignant colon neoplasm.